• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. CROWN PRT PERICARDIAL HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. CROWN PRT PERICARDIAL HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number CNA19
Medical Device Problem Code Degraded (1153)
Health Effect - Clinical Code Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 03/09/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The manufacturing and material records for the crown prt aortic pericardial heart valve, model # cna19, s/n #(b)(4), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a crown prt aortic pericardial heart valve at the time of manufacture and release.Since the device was not returned to the manufacturer, further investigation on the device can not be performed and definite root cause of this event can not be established.However, the review of the manufacturing and material records performed showed that this valve satisfied all material, visual, and performance standards required for a crown prt aortic pericardial heart valve at the time of manufacture and release.It should be noted that structural valve deterioration is listed as a possible adverse event in the crown ifu.The event is, therefore, a known inherent risk of the device.It is possible that the patient's clinical history and risk factors contributed to the reported event.However, since no information on this regards has been provided, this cannot be ultimately confirmed.The manufacturer is following up with the field.Should further information be received, the manufacturer will provide an update to the reporting activity as applicable.Unknown disposition.
 
Event or Problem Description
The manufacturer was informed of the following event: the patient who had crown valve implantation surgery with midline incision simultaneous with cabg (lita-lad, ao-svg-rca) on (b)(6) 2016, underwent the emergency surgery due to severe aortic regurgitation caused by svd on (b)(6) 2022.The valve was explanted and pvs21 was implanted instead.Echo preformed after re-avr showed no leakage and no malfunction of the perceval valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CROWN PRT PERICARDIAL HEART VALVE
Common Device Name
TISSUE HEART VALVES
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key14003924
Report Number3004478276-2022-00141
Device Sequence Number20116597
Product Code LWR
UDI-Device Identifier00896208000504
UDI-Public(01)00896208000504(240)CNA19(17)170531
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P060038
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/31/2017
Device Model NumberCNA19
Device Catalogue NumberCNA19
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/09/2022
Initial Report FDA Received Date04/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/09/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age86 YR
Patient SexFemale
Patient Weight44 KG
-
-